+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biotage AB (BIOT) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 59 Pages
  • August 2024
  • GlobalData
  • ID: 1292279
Biotage AB (BIOT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the analyst to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Biotage AB (Biotage) is a life sciences company. It provides products and solutions from drug discovery and development to diagnostics and analytical testing. The company’s product portfolio includes machines for organic synthesis, flash chromatography, evaporation, peptide synthesis and purification, sample preparation, biomolecule purification and oligosynthesis. It also provides scavengers, reagents and related spare parts and accessories. Biotage provides its services and solutions to pharmaceutical, biotechnology and diagnostics companies. It also serves contract research and manufacturing organizations alongside clinical, forensic and academic laboratories. The company operates through its subsidiaries in Sweden, the UK, Germany, France, Italy, Switzerland, the US, Japan, China, South Korea, Singapore and India. Biotage is headquartered in Uppsala, Sweden.

Biotage AB Key Recent Developments

  • Apr 25, 2024: Biotage AB (publ Interim report January-March 2024
  • Apr 04, 2024: Biotage AB Publishes its 2023 Annual Report and Corporate Governance Report
  • Feb 15, 2024: Biotage Appoints Andrew Kellett as CFO
  • Dec 07, 2023: Gyros Protein Technologies and Biotage Partner to Advance Peptide Purification Efficiency with New Automated Solution

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Biotage AB - Key Facts
  • Biotage AB - Key Employees
  • Biotage AB - Key Employee Biographies
  • Biotage AB - Major Products and Services
  • Biotage AB - History
  • Biotage AB - Company Statement
  • Biotage AB - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Biotage AB - Business Description
  • Product Category: Analytical Testing
  • Performance
  • Product Category: Biologics and Advanced Therapeutics
  • Performance
  • Product Category: Diagnostics
  • Performance
  • Product Category: Scale Up
  • Performance
  • Product Category: Small Molecules and Synthetic Therapeutics
  • Performance
  • Product Category: Water and Environmental Testing
  • Performance
  • Geographical Segment: China
  • Performance
  • Geographical Segment: EMEA
  • Performance
  • Geographical Segment: India
  • Performance
  • Geographical Segment: Japan
  • Performance
  • Geographical Segment: North and South America
  • Performance
  • Geographical Segment: Other APAC
  • Performance
  • Geographical Segment: South Korea
  • Performance
  • R&D Overview
  • Biotage AB - Corporate Strategy
  • Biotage AB - SWOT Analysis
  • SWOT Analysis - Overview
  • Biotage AB - Strengths
  • Biotage AB - Weaknesses
  • Biotage AB - Opportunities
  • Biotage AB - Threats
  • Biotage AB - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Biotage AB, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
  • Biotage AB, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
  • Biotage AB, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Apr 25, 2024: Biotage AB (publ Interim report January-March 2024
  • Apr 04, 2024: Biotage AB Publishes its 2023 Annual Report and Corporate Governance Report
  • Feb 15, 2024: Biotage Appoints Andrew Kellett as CFO
  • Dec 07, 2023: Gyros Protein Technologies and Biotage Partner to Advance Peptide Purification Efficiency with New Automated Solution
  • Oct 25, 2023: Biotage Announces Interim report January-September 2023
  • Sep 11, 2023: Biotage Appoints Andrew Kellett as Interim CFO
  • Apr 27, 2023: Biotage announces interim report January - March 2023
  • Apr 27, 2023: Biotage resolutions at the annual general meeting on April 27, 2023
  • Apr 06, 2023: Biotage AB (publ) publishes its 2022 Annual Report and Corporate Governance Report
  • Mar 27, 2023: Biotage Notice of Annual General Meeting
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Analyst
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Biotage AB, Key Facts
  • Biotage AB, Key Employees
  • Biotage AB, Key Employee Biographies
  • Biotage AB, Major Products and Services
  • Biotage AB, History
  • Biotage AB, Subsidiaries
  • Biotage AB, Key Competitors
  • Biotage AB, Ratios based on current share price
  • Biotage AB, Annual Ratios
  • Biotage AB, Interim Ratios
  • Biotage AB, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
  • Biotage AB, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
  • Biotage AB, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Biotage AB, Performance Chart (2019 - 2023)
  • Biotage AB, Ratio Charts
  • Biotage AB, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
  • Biotage AB, Pharmaceuticals & Healthcare, Deals by Type, 2018 to YTD 2024

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Phenomenex Inc
  • Anton Paar GmbH
  • Waters Corp
  • Interchim SA
  • Agilent Technologies Inc
  • SiliCycle Inc
  • Johnson Matthey Plc
  • Gyros Protein Technologies AB
  • Gilson Inc
  • Cem Corp
  • Teledyne Isco, Inc.
  • Labconco Corp